JWM
ORIC icon

JPL Wealth Management’s Oric Pharmaceuticals ORIC Stock Holding History

JPL Wealth Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2K Buy
+95
New +$1.08K ﹤0.01% 1146
2025
Q4 		– Sell
-95
Closed -$1.14K – 808
2025
Q3 		$1.14K Buy
+95
New +$999 ﹤0.01% 977

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

JPL Wealth Management's ORIC Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 95 shares worth $1.2K. The stake represents ﹤0.01% of the portfolio and ranks #1146 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in ORIC as recently as Q3 2025.

JPL Wealth Management first reported a position in ORIC in Q3 2025 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • JPL Wealth Management held 95 shares of Oric Pharmaceuticals worth $1.2K as of Q1 2026.
  • Oric Pharmaceuticals was a new JPL Wealth Management position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #1146 holding.
  • JPL Wealth Management first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.